Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

Market Cap	1.00B
Revenue (ttm)	410.22M
Net Income (ttm)	-29.59M
Shares Out	2.13B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	955,000
Average Volume	1,119,000
Open	0.4600
Previous Close	0.4700
Day's Range	0.4500 - 0.4650
52-Week Range	0.0670 - 0.6500
Beta	0.15
RSI	47.41
Earnings Date	May 9, 2025

About HKG:8189

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. The company operates through two segments, Biological Compound Fertilisers Products, and Elderly Care and Health Care Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas that are used for the facilitation of balanced growth of ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2000
• Employees: 260
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8189

Financial Performance

In 2024, HKG:8189's revenue was 385.48 million, a decrease of -3.14% compared to the previous year's 398.00 million. Losses were -27.80 million, 37.9% more than in 2023.

Financial numbers in CNY